Lipid-Lowering Drug Use and Breast Cancer in Older Women: A Prospective Study

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of Women's Health

• Publication date

  2003-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1089/154099903322447710PMID 14588125
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer risk among statin users: A population‐based cohort study

  2005cited by this paper
• Clinical usage of hypolipidemic and antidiabetic drugs in the prevention and treatment of cancer.

  2005cited by this paper
• The association between 3‐hydroxy‐3‐methylglutaryl conenzyme A inhibitor use and breast carcinoma risk among postmenopausal women

  2004cited by this paper
• Insulin resistance, its consequences for the clinical course of the disease, and possibilities of correction in endometrial cancer

  2004cited by this paper
• The risk of cancer in users of statins.

  2004cited by this paper
• Of cancer and cholesterol: studies elucidate anticancer mechanisms of statins.

  2003cited by this paper
• Statin Use and the Risk of Breast and Prostate Cancer

  2002cited by this paper
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.

  2002cited by this paper
• Statin use, hyperlipidaemia, and the risk of breast cancer

  2002influential reference
• 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and the risk of cancer: a nested case-control study.

  2000cited by this paper
• The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels

  2000cited by this paper
• Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol lowering.

  2000cited by this paper
• Cohort studies of fat intake and the risk of breast cancer--a pooled analysis.

  2000cited by this paper
• Elevated Serum Estradiol and Testosterone Concentrations Are Associated with a High Risk for Breast Cancer

  1999cited by this paper
• Reduction of mouse mammary tumor formation and metastasis by lovastatin, an inhibitor of the mevalonate pathway of cholesterol synthesis

  1998cited by this paper
• Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group.

  1998cited by this paper
• Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials.

  1997cited by this paper
• Chemoprevention by Pravastatin, a 3‐Hydroxy‐3‐methylglutaryl‐coenzyme A Reductase Inhibitor, of N‐Methyl‐N‐nitrosourea‐induced Colon Carcinogenesis in F344 Rats

  1996cited by this paper
• The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

  1996cited by this paper
• Bone mineral density and risk of breast cancer in older women: the study of osteoporotic fractures. Study of Osteoporotic Fractures Research Group.

  1996cited by this paper
• Cohort studies of fat intake and the risk of breast cancer--a pooled analysis.

  1996cited by this paper
• Role of oxygen free radicals in cancer development.

  1996cited by this paper
• Inhibition of lung tumor cell growth in vitro and mouse lung tumor formation by lovastatin.

  1996cited by this paper
• Meta-analysis of animal experiments: elucidating relationships between dietary fat and mammary tumor development in rodents.

  1994cited by this paper
• Cell cycle-specific growth inhibition of human breast cancer cells induced by metabolic inhibitors.

  1993cited by this paper
• Dietary lipids and the low blood cholesterol-cancer association.

  1992cited by this paper
• Cholesterol inhibition, cancer, and chemotherapy.

  1992cited by this paper
• Cholesterol and mevalonic acid modulation in cell metabolism and multiplication.

  1992cited by this paper
• Manual for Staging of Cancer

  1992cited by this paper
• Cancer mortality and lipid and lipoprotein levels. Lipid Research Clinics Program Mortality Follow-up Study.

  1990cited by this paper
• Dietary fat and cancer: consistency of the epidemiologic data, and disease prevention that may follow from a practical reduction in fat consumption

  1990cited by this paper
• Total serum cholesterol and triglycerides and risk of breast cancer: a prospective study of 24,329 Norwegian women.

  1990cited by this paper
• Dietary factors and risk of breast cancer: combined analysis of 12 case-control studies.

  1990cited by this paper
• Appendicular bone density and age predict hip fracture in women. The Study of Osteoporotic Fractures Research Group.

  1990cited by this paper
• Appendicular Bone Density and Age Predict Hip Fracture in Women

  1990cited by this paper
• Cancer incidence and cancer mortality in relation to serum cholesterol.

  1989cited by this paper
• Serum cholesterol and cancer in the NHANES I epidemiologic followup study. National Health and Nutrition Examination Survey.

  1987cited by this paper
• SERUM CHOLESTEROL AND CANCER IN THE NHANES I EPIDEMIOLOGIC FOLLOWUP STUDY

  1987cited by this paper
• Effects of mevinolin and mevalonate on cell growth in several transformed cell lines

  1986cited by this paper
• Breast cancer and serum cholesterol.

  1982cited by this paper
• Cancer incidence in humans: relationship to plasma lipids and relative weight.

  1982cited by this paper
• Serum cholesterol and risk of death from cancer and other causes in three Chicago epidemiological studies.

  1981cited by this paper
• Letter: A shower of aortic aneurysms.

  1974cited by this paper
• Cancer, cholesterol and cholestyramine.

  1972cited by this paper
• [Cholesterol and cholestyramine].

  1970cited by this paper

• Genetic association of lipids and lipid-lowering drug target genes with breast cancer

  2025cites this paper
• Obesity-Related Cancers in Relation to Use of Statins and Testosterone Replacement Therapy Among Older Women: SEER-Medicare 2007–2015

  2025cites this paper
• The role of statins in breast cancer survivors

  2025influential citation
• The Effect of Statins on Markers of Breast Cancer Proliferation and Apoptosis in Women with In Situ or Early-Stage Invasive Breast Cancer

  2024cites this paper
• Circulating lipids, lipid-lowering drug targets, and breast cancer risk: Comprehensive evidence from Mendelian randomization and summary data-based Mendelian randomization

  2024cites this paper
• Inhibition of tumor migration and invasion by fenofibrate via suppressing epithelial-mesenchymal transition in breast cancers.

  2024cites this paper
• Comprehensive Mendelian randomization analysis of low-density lipoprotein cholesterol and multiple cancers

  2024cites this paper
• A review of research on the intersection between breast cancer and cardiovascular research in the Women’s Health Initiative (WHI)

  2023cites this paper
• Exploring the therapeutic potential of simvastatin in pancreatic neuroendocrine neoplasms: insights into cell cycle regulation and apoptosis

  2023cites this paper
• The Interplay between Atherosclerosis and Cancer: Breast Cancer Cells Increase the Expression of Endothelial Cell Adhesion Markers

  2023cites this paper
• Associations of genetically proxied inhibition of HMG-CoA reductase, NPC1L1, and PCSK9 with breast cancer and prostate cancer

  2022cites this paper
• ZMYND8 is a master regulator of 27-hydroxycholesterol that promotes tumorigenicity of breast cancer stem cells

  2022cites this paper
• The Impact of Statin Use and Breast Cancer Recurrence - A Retrospective Study in Singapore

  2022cites this paper
• Effect of statins use on risk and prognosis of breast cancer: a meta-analysis

  2021cites this paper
• Statins downregulate YAP and TAZ and exert anti-cancer effects in canine mammary tumor cells.

  2021cites this paper
• Medication use and mammographic breast density

  2021cites this paper
• Polyunsaturated Fatty Acids Mediated Regulation of Membrane Biochemistry and Tumor Cell Membrane Integrity

  2021cites this paper
• Efficacy of fluvastatin and aspirin for prevention of hormonally insensitive breast cancer

  2021cites this paper
• Apolipoprotein-mediated regulation of lipid metabolism induces distinctive effects in different types of breast cancer cells

  2020cites this paper
• LDL, HDL and endocrine-related cancer: from pathogenic mechanisms to therapies.

  2020cites this paper
• Role of Hedgehog Signaling in Breast Cancer: Pathogenesis and Therapeutics

  2019cites this paper
• The risk of cancer in statin users : a clinical and genetic approach

  2019cites this paper
• HDL and LDL: Potential New Players in Breast Cancer Development

  2019cites this paper
• Statins: A Conceivable Remedial Role for the Regulation of Cancer Progression

  2019cites this paper
• Can cardiovascular drugs support cancer treatment? The rationale for drug repurposing.

  2019cites this paper
• Beyond the boundaries of cardiology: still untapped anticancer properties of the cardiovascular system-related drugs.

  2019cites this paper
• Omega-3 fatty acids, membrane remodeling and cancer prevention.

  2018cites this paper
• Non-hormonal Chemoprevention

  2018cites this paper
• The effect of genetic variants on the relationship between statins and breast cancer in postmenopausal women in the Women’s Health Initiative observational study

  2018cites this paper
• The isomiR-140-3p-regulated mevalonic acid pathway as a potential target for prevention of triple negative breast cancer

  2018cites this paper
• Association Between Migraine and Breast Cancer Risk: A Population-Based Cohort Study and Literature Review

  2018cites this paper
• The significance of cholesterol and its metabolite, 27-hydroxycholesterol in breast cancer.

  2017cites this paper
• Gender related differences in treatment and response to statins in primary and secondary cardiovascular prevention: The never‐ending debate

  2017cites this paper
• Exploring association between statin use and breast cancer risk: an updated meta-analysis

  2017cites this paper
• The Contribution of Cholesterol and Its Metabolites to the Pathophysiology of Breast Cancer

  2016cites this paper
• Statin Use and Breast Cancer Risk in the Nurses' Health Study

  2016cites this paper
• Effect of Lipophilic and Hydrophilic Statins on Breast Cancer Risk in Thai Women: A Cross-sectional Study

  2016cites this paper
• Statins are Associated With a Reduced Risk of Brain Cancer

  2016cites this paper
• Statins and risk of breast cancer recurrence

  2016cites this paper
• Risk-Reducing (Chemopreventive) Agents in Breast Cancer Prevention

  2016cites this paper
• Novel applications of COX-2 inhibitors, metformin, and statins for the primary chemoprevention of breast cancer.

  2016cites this paper
• The Effect of Atorvastatin on Breast Cancer Biomarkers in High-Risk Women

  2016cites this paper
• Advances in Lipid Therapy: The Role of Lipid Treatment in Women in Primary Prevention.

  2016cites this paper
• Cardiovascular comorbidities and survival of lung cancer patients: Medicare data based analysis.

  2015cites this paper
• Effects of statin use on volumetric mammographic density: results from the KARMA study

  2015cites this paper
• Statins as anti-cancer therapy; Can we translate preclinical and epidemiologic data into clinical benefit?

  2015cites this paper
• Statins and breast cancer stage and mortality in the Women’s Health Initiative

  2015cites this paper
• ACUTE LEUKEMIAS XV

  2015cites this paper
• Statin use and breast cancer survival and risk: a systematic review and meta-analysis

  2015cites this paper
• New cholesterol guidelines and primary prevention in women.

  2015cites this paper
• The Association between Charlson Comorbidity Index and the Medical Care Cost of Cancer: A Retrospective Study

  2015cites this paper
• The role of systemic metabolism in breast cancer progression

  2015cites this paper
• Statin use and the risk of breast cancer: a population-based case–control study

  2014cites this paper
• Targeting Intracellular Cholesterol is a Novel Therapeutic Strategy for Cancer

  2014cites this paper
• Novel prospects of statins as therapeutic agents in cancer.

  2014cites this paper
• Hypercholesterolemia induces angiogenesis and accelerates growth of breast tumors in vivo.

  2014cites this paper
• Melatonin potentiates the anti‐tumour effect of pravastatin in rat mammary gland carcinoma model

  2014cites this paper
• Targeting Intracellular Cholesterol is a Novel Therapeutic Strategy for Cancer Treatment

  2014cites this paper
• Simvastatin Radiosensitizes Differentiated and Stem‐Like Breast Cancer Cell Lines and Is Associated With Improved Local Control in Inflammatory Breast Cancer Patients Treated With Postmastectomy Radiation

  2014cites this paper
• Review Article Evaluation of the effect of genetic variation on the relationship between statins, cardiovascular disease and cancer

  2013cites this paper
• Evaluation of the effect of genetic variation on the relationship between statins, cardiovascular disease and cancer.

  2013cites this paper
• Mammary tumor growth and pulmonary metastasis are enhanced in a hyperlipidemic mouse model

  2013cites this paper
• Simvastatin induces caspase-dependent apoptosis and activates P53 in OCM-1 cells.

  2013cites this paper
• Statins and Breast Cancer: Future Directions in Chemoprevention

  2013cites this paper
• A clinical trial of lovastatin for modification of biomarkers associated with breast cancer risk

  2013cites this paper
• Beyond aspirin—cancer prevention with statins, metformin and bisphosphonates

  2013cites this paper
• The Mevalonate Pathway: A Potential Therapeutic Target for JAK2-driven Myeloproliferative Neoplasms

  2013cites this paper
• Prospective Analysis of Association between Statin Use and Breast Cancer Risk in the Women's Health Initiative

  2013influential citation
• Long-Term Statin Use and Risk of Ductal and Lobular Breast Cancer among Women 55 to 74 Years of Age

  2013cites this paper
• Anticancer activity of the cholesterol exporter ABCA1 gene.

  2012cites this paper
• Personalizing cardiovascular disease prevention among breast cancer survivors

  2012cites this paper
• Statin use and the risk of bladder cancer: a population-based case–control study

  2012cites this paper
• Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway.

  2012cites this paper
• A short-term biomarker modulation study of simvastatin in women at increased risk of a new breast cancer

  2012cites this paper
• Gain-of-Function Effects of Mutant p53 Explored Using a Three- Dimensional Culture Model of Breast Cancer

  2012cites this paper
• Statin use and the risk of kidney cancer: a population-based case–control study

  2012cites this paper
• Statins and cancer: current and future prospects.

  2012cites this paper
• Pharmacological Actions of Statins: A Critical Appraisal in the Management of Cancer

  2012cites this paper
• Statin use and risk of breast cancer: a meta-analysis of observational studies

  2012influential citation
• Statin use and the risk of female lung cancer: a population-based case-control study.

  2012cites this paper
• Mecanismos moleculares de las estatinas sobre el cáncer

  2012cites this paper
• Antitumor effects of atorvastatin in the chemoprevention of rat mammary carcinogenesis

  2011cites this paper
• Common cardiovascular medications in cancer therapeutics.

  2011cites this paper
• Statin Use and the Risk of Pancreatic Cancer: A Population-Based Case-Control Study

  2011cites this paper
• Simvastatin Prevents Skeletal Metastasis of Breast Cancer by an Antagonistic Interplay between p53 and CD44*

  2011cites this paper
• Statin Use and the Risk of Liver Cancer: A Population-Based Case–Control Study

  2011cites this paper
• Antineoplastic Effects of Simvastatin in Experimental Breast Cancer

  2011cites this paper
• Effect of concomitant statin, metformin, or aspirin on rituximab treatment for diffuse large B-cell lymphoma

  2011cites this paper
• Statin use and the risk of colorectal cancer: a population-based case-control study.

  2011cites this paper
• Statins Are Associated With a Reduced Risk of Gastric Cancer: A Population-Based Case–Control Study

  2011cites this paper
• Rosuvastatin in the chemoprevention of N-methyl-N-nitrosourea-induced mammary carcinogenesis in female rats.

  2011cites this paper
• Lipid raft localization of EGFR alters the response of cancer cells to the EGFR tyrosine kinase inhibitor gefitinib

  2011cites this paper
• Simvastatin induces derepression of PTEN expression via NFkappaB to inhibit breast cancer cell growth.

  2010cites this paper
• Effects of lovastatin on breast cancer cells: a proteo-metabonomic study

  2010cites this paper
• Statins and pancreatic cancer risk: a nested case–control study

  2010cites this paper
• Tumorigenesis and Neoplastic Progression Role of Cholesterol in the Development and Progression of Breast Cancer

  2010cites this paper
• Statin use and cancer risk: a comprehensive review

  2010cites this paper
• Non-Hormonal Medications and Chronic Diseases

  2010cites this paper
• A Role For Lipid Rafts In Egfr Tki Resistance In Breast Cancer

  2010cites this paper
• Antineoplastic Effects of N-3 Polyunsaturated Fatty Acids in Combination With Drugs and Radiotherapy: Preventive and Therapeutic Strategies

  2009cites this paper